GIURATO, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 5.615
AS - Asia 1.210
EU - Europa 806
SA - Sud America 269
Continente sconosciuto - Info sul continente non disponibili 202
AF - Africa 23
OC - Oceania 3
Totale 8.128
Nazione #
US - Stati Uniti d'America 5.515
SG - Singapore 519
IT - Italia 241
BR - Brasile 213
CN - Cina 207
VN - Vietnam 134
RU - Federazione Russa 133
HK - Hong Kong 123
IE - Irlanda 77
BD - Bangladesh 74
FI - Finlandia 65
DE - Germania 63
GB - Regno Unito 58
JP - Giappone 48
CA - Canada 47
FR - Francia 43
UA - Ucraina 32
IN - India 26
MX - Messico 25
AR - Argentina 22
SE - Svezia 22
PL - Polonia 20
NL - Olanda 18
EC - Ecuador 14
ID - Indonesia 11
KR - Corea 11
CO - Colombia 6
ES - Italia 6
JM - Giamaica 6
PH - Filippine 6
PK - Pakistan 6
IQ - Iraq 5
MY - Malesia 5
PY - Paraguay 5
RO - Romania 5
TT - Trinidad e Tobago 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
GT - Guatemala 4
HN - Honduras 4
LT - Lituania 4
SA - Arabia Saudita 4
TH - Thailandia 4
TR - Turchia 4
AM - Armenia 3
AT - Austria 3
CL - Cile 3
CR - Costa Rica 3
EG - Egitto 3
KE - Kenya 3
MA - Marocco 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
IL - Israele 2
MD - Moldavia 2
MM - Myanmar 2
PE - Perù 2
SC - Seychelles 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
MV - Maldive 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 7.929
Città #
Wilmington 1.095
Houston 940
Woodbridge 639
Ashburn 336
Singapore 302
San Jose 231
Fairfield 188
Chandler 153
Hong Kong 119
Council Bluffs 116
Beijing 99
Seattle 94
Cambridge 76
New York 76
Santa Clara 68
Los Angeles 67
Dublin 65
Rome 50
Helsinki 49
Ann Arbor 48
The Dalles 46
Medford 43
Ho Chi Minh City 41
Tokyo 41
North Bergen 37
Dallas 34
Denver 32
Hanoi 31
Chicago 29
Milan 25
Buffalo 24
Menlo Park 24
São Paulo 24
Munich 23
Lawrence 20
Colorado Springs 19
Moscow 19
Jacksonville 18
Lauterbourg 18
Phoenix 18
Warsaw 17
Frankfurt am Main 13
Orem 13
Redondo Beach 13
Atlanta 12
London 12
Toronto 12
Rio de Janeiro 11
Shanghai 11
Montreal 10
San Diego 10
San Francisco 10
Boardman 9
Brooklyn 9
Chennai 9
Mexico City 9
Naples 9
Palo Alto 9
Salt Lake City 9
Stockholm 9
Charlotte 8
Sarno 8
Belo Horizonte 7
Dearborn 7
Miami 7
Monmouth Junction 7
Da Nang 6
Lappeenranta 6
Manchester 6
Poplar 6
Seoul 6
Cleveland 5
Elk Grove Village 5
Florence 5
Lahore 5
Newark 5
Nuremberg 5
Washington 5
Bangkok 4
Farmington 4
Guatemala City 4
Guayaquil 4
Haiphong 4
Hangzhou 4
Kingston 4
Kuala Lumpur 4
La Puente 4
Louisville 4
Princeton 4
Querétaro 4
Quito 4
Roubaix 4
Suzhou 4
São José dos Campos 4
Thái Nguyên 4
Amsterdam 3
Baghdad 3
Birmingham 3
Bologna 3
Bắc Ninh 3
Totale 5.785
Nome #
Risk of contrast induced nephropathy in diabetic patients affected by critical limb ischemia and diabetic foot ulcers treated by percutaneous transluminal angioplasty of lower limbs 488
Long term outcomes of diabetic haemodialysis patients with critical limb ischemia and foot ulcer 444
Limb Salvage in Patients With Diabetes Is Not a Temporary Solution but a Life-Changing Procedure 441
Management of negative pressure wound therapy in the treatment of diabetic foot ulcers 435
Non-healing foot ulcers in diabetic patients: General and local interfering conditions and management options with advanced wound dressings 424
Below-the-ankle arterial disease severely impairs the outcomes of diabetic patients with ischemic foot ulcers 262
Critical limb ischemia: Current challenges and future prospects 260
Rearfoot Transcutaneous Oximetry is a Useful Tool to Highlight Ischemia of the Heel 234
Physician experts in diabetes are natural team leaders for managing diabetic patients with foot complications. A position statement from the Italian diabetic foot study group 233
Endovascular Distal Plantar Vein Arterialization in Dialysis Patients With No-Option Critical Limb Ischemia and Posterior Tibial Artery Occlusion: A Technique for Limb Salvage in a Challenging Patient Subset 221
Recurrence of Critical Limb Ischemia after Endovascular Intervention in Patients with Diabetic Foot Ulcers 221
Limb Salvage in Diabetic Patients With Ischemic Heel Ulcers 217
Peripheral arterial disease in patients with renal-diabetic foot ulcers 217
Diabetes, Lower-Extremity Amputation, and Death. Diabetes Care 2015;38: 1852-1857 208
Osteomyelitis in diabetic foot: A comprehensive overview 205
Effectiveness of Sucrose Octasulfate Dressing in the Treatment of Neuro-Ischaemic Diabetic Foot Heel Ulcers: A Retrospective Single arm Study 204
The Effectiveness of Negative Pressure Therapy in Diabetic Foot Ulcers with Elevated Protease Activity: A Case Series 196
Procalcitonin Is a Prognostic Marker of Hospital Outcomes in Patients with Critical Limb Ischemia and Diabetic Foot Infection 191
Impact of heart failure and dialysis in the prognosis of diabetic patients with ischemic foot ulcers 189
Attending an integrated nephrology and diabetology outpatient service can improve diabetic kidney disease treatment: a single-center experience 170
Letter Regarding “The Prostacyclin Analogue Iloprost as an Early Predictor of Successful Revascularization in Diabetic Patients Affected by Critical Limb Ischemia and Foot Ulcers” 169
Foot Revascularization Avoids Major Amputation in Persons with Diabetes and Ischaemic Foot Ulcers 150
Below-the-ankle arterial disease: a new marker of coronary artery disease in patients with diabetes and foot ulcers 118
Hospital Readmission in Patients With Diabetic Foot Ulcers: Prevalence, Causes, and Outcomes 116
Risk Factors for Ulcer Recurrence in Diabetic Patients Managed by an Integrated Foot Care Protocol 112
Macrophage Activation and M2 Polarization in Wound Bed of Diabetic Patients Treated by Dermal/Epidermal Substitute Nevelia 112
Early Treatment of Acute Stage 0/1 Diabetic Charcot Foot Can Avoid Major Amputations at One Year 109
Microbiological and Clinical Characteristics of Infected Diabetic Foot Ulcers Managed in a Tertiary Level Diabetic Foot Service 108
Peripheral Blood Mononuclear Cells: A New Frontier in the Management of Patients with Diabetes and No-Option Critical Limb Ischaemia 105
Prevalence of Diabetes Mellitus and Clinical Differences in Patients with Severe Osteoporosis and Fragility Fractures 104
Diabetic Foot Osteomyelitis in Patients with and without Peripheral Arterial Disease: Two Different Diseases? 100
Diabetic Polyneuropathy and Physical Activity in Type 1 Diabetes Mellitus: A Cross-Sectional Study 100
The Neuro-Ischaemic Charcot Foot: Prevalence, Characteristics and Severity of Peripheral Arterial Disease in Acute Charcot Neuro-Arthropathy 98
The Immune-Centric Revolution in the Diabetic Foot: Monocytes and Lymphocytes Role in Wound Healing and Tissue Regeneration-A Narrative Review 96
Bioactive Glass in a Multi Drug Resistance Osteomyelitis in Diabetic Foot: Case Report 95
Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects 95
Characteristics and outcome for persons with diabetic foot ulcer and no-option critical limb ischemia 89
Effectiveness of fast-track pathway for diabetic foot ulcerations 85
Incidence and causes of major amputation in patients with diabetic foot ulcers: data from a retrospective study 83
Prevalence, clinical aspects and outcomes in a large cohort of persons with diabetic foot disease: Comparison between neuropathic and ischemic ulcers 78
Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems 78
Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers 77
The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)—Rationale and Meta-Analysis of Observational Studies 64
Response to the letter of Tariq and colleagues on the paper "below‑the‑ankle arterial disease: a new marker of coronary artery disease in patients with diabetes and foot ulcers" 63
Management of diabetic persons with foot ulceration during COVID-19 health care emergency: Effectiveness of a new triage pathway 59
Correction to: Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects 53
Use of Nevelia Dermal-Epidermal Regenerative Template in the Management of Ischemic Diabetic Foot Postsurgical Wounds 52
Diabetic Foot Infections: The Diagnostic Challenges 37
Predictive factors of major amputation in patients with diabetic foot ulcers treated by peripheral blood mononuclear cells 32
Metabolic and renal effects of combined SGLT-2 inhibitors and GLP1-R agonists therapy in type 2 diabetes: a real-world analysis across DKD and non-DKD patients 31
Totale 8.128
Categoria #
all - tutte 25.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.479


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022179 0 0 0 2 2 24 15 7 11 19 21 78
2022/2023357 20 46 6 43 51 70 37 26 35 1 15 7
2023/2024138 11 3 20 2 9 27 25 4 8 1 5 23
2024/2025862 30 142 73 49 60 121 56 46 59 79 74 73
2025/20262.310 112 201 257 244 232 79 311 198 219 175 145 137
2026/2027958 135 184 354 285 0 0 0 0 0 0 0 0
Totale 8.128